Independent clinical predictors of clinical outcomes
| Predictors | HR | 95% CI | p Value |
|---|---|---|---|
| Death | |||
| Age >70 | 4.264 | 2.540 to 7.160 | <0.001 |
| Previous PCI | 2.205 | 1.235 to 3.934 | 0.007 |
| Thrombotic lesion | 4.716 | 2.544 to 8.740 | <0.001 |
| Ostial lesion | 2.416 | 1.161 to 5.217 | 0.019 |
| TVR | |||
| Stent type (SES vs PES) | 0.567 | 0.395 to 0.813 | 0.002 |
| Previous CABG | 2.393 | 1.440 to 3.977 | 0.001 |
| Chronic total occlusion | 2.786 | 1.731 to 4.484 | <0.001 |
| Left main lesion | 1.854 | 1.022 to 3.363 | 0.042 |
| MI | |||
| Age >70 | 2.167 | 1.290 to 3.639 | 0.003 |
| Hyperlipidaemia | 2.188 | 1.301 to 3.680 | 0.003 |
| Previous MI | 1.843 | 1.083 to 3.173 | 0.024 |
| MACE | |||
| Age >70 | 1.646 | 1.272 to 2.127 | <0.001 |
| Previous CABG | 1.989 | 1.297 to 3.049 | 0.002 |
| Chronic total occlusion | 2.265 | 1.491 to 3.440 | <0.001 |
| Hyperlipidaemia | 1.383 | 1.062 to 1.802 | 0.016 |
| Left main lesion | 1.738 | 1.044 to 2.895 | 0.034 |
CABG, coronary-artery bypass grafting; MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent; SES, sirolimus-eluting stent; TVR, target vessel revascularisation.